Analysis of the potential factors affecting the quality of chemical generic drugs in ChinaCHEN Zhen, YANG Jian-hong, ZHANG Yan-yan, HAN Peng1345-1350
Innovation efficiency of pharmaceutical industry in China and its influencing factors: a spatial econometric analysisCAO Yang, ZHANG Wen-si1351-1356
Review of new launches by FDA in 2016 and the latest progress of investigational drugs in key therapeutic areasCHEN Ling, LIU Yan-hong, ZOU Xu, HUANG Wen-long1357-1369
Effects of APIs, excipients, formulations and technologies on the dissolution profiles of solid oral preparationsXUE Jing, XU Ming-di, NAN Nan, LI Ya-ping1370-1375
Isolation of endophytic fungi from Astragalus membranaceus (Fisch.) Bge.and analysis of their secondary metabolitesZHENG Xue, XU Hui-chao, LI Wei, ZHENG Chun-ying1376-1381
The discovery of mitochondria-targeted antioxidant SS-31 (H-D-Arg-Dmt-Lys-Phe-NH2) and its research progressCHEN Zhen, LU Dan-dan, QIN Ya-juan, LI Ting-you1382-1389
Advances in research of CDK9 and their inhibitorsYI Rui, YI Hong-hong, HU Gao-yun, LI Qian-bin1390-1397
Progress in research of P2Y12 receptor antagonists antiplatelet drugsDONG Hui-yu, CHENG Xian-hua, ZHONG Wen-ying, WU Yan-zhuo, XU Ming-bo1406-1411
Clinical efficacy and safety of reteplase combined with ticagrelor for the treatment of acute ST-segment elevation myocardial infarctionLI Zheng-rong, ZHAO Jian-ye, ZHANG Zong-lin, SHI Zeng-cheng, ZHANG Shou-wen, WEI Yan-jin1412-1417